Global Coronary Stents Market New Report by Data Bridge Market Research

Dallas, TX, October 23, 2016 --(PR.com)-- The market for Coronary Stents is expected to reach USD 6.1 billion by 2022, growing at 2.5% during the forecast years to 2022.

The market is segmented on the basis of product, material, application, absorption rate, drug, end-user, distribution channel, and geography.

Request for sample pages: http://databridgemarketresearch.com/reports/global-coronary-stents-market/

On the basis of product the coronary stents is segmented into dual therapy stent, bioresorbable vascular scaffold (BVS), drug eluting stent (DES), bio-engineered stent, and bare metal stent. Drug eluting stent market is segmented into biodegradable and non-biodegradable.

Based on drug, the market is segmented into paclitaxel, and limus-based drugs.
On the basis of material the market is segmented into stainless steel, cobalt alloy metal, gold, tantalum, nitinol, and polymers.

Based on application, the market is segmented into coronary artery disease, and peripheral artery disease.

Based on absorption rate, the market is segmented into slow-absorption stents, and fast-absorption stents.

On the basis of end-user, the market is segmented into hospitals, and cardiac centers.

Based on geography the market is segmented into North America, Europe, Asia-Pacific, South America, Middle East and Africa and, Rest of the World. North America is expected to be the largest market whereas Asia-Pacific is the fastest growing market.

Read more: http://databridgemarketresearch.com/reports/global-coronary-stents-market/

Global coronary stents market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market. The report also covers company share analysis for Global, U.S., Europe, Germany, Asia-Pacific, Middle East & Africa, North America and South America.

The major players operating in this market are Abbott Vascular, SciTech, Boston Scientific Corporation, Medinol Ltd, iVascular SLU, Stentys SA, Elixir Medical Corporation, Inspire MD, Hexacath, Medtronic, Orbusneich, Andramed GmbH, Cordis Corporation, Endocor GmbH, Eurocor GmbH, Comed B.V., MicroPort Scientific Corporation, Degania Silicone Ltd., Amaranth Medical, Inc., Terumo Corporation, Meril Life Sciences Pvt. Ltd., Elixir Medical Corporation, InSitu Technologies Inc., Alvimedica, Biotronik SE & Co. KG, AMG International GmbH, Arthesys, Translumina GmbH, Lepu Medical, Accura, CeloNova BioSciences, Inc., Minvasys, Svelte Medical, B. Braun Melsungen AG and, Eucatech AG among other companies.

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.